Please check your internet connection and try again.
# Magnesium Sulfate
## Overview
Magnesium sulfate is an essential mineral and electrolyte. It plays a crucial role in numerous biochemical reactions within the body, including neuromuscular transmission, cardiac excitability, and enzyme function.
## Primary Indications
* Treatment of hypomagnesemia
* Management of eclampsia and pre-eclampsia
* Treatment of torsades de pointes
* Management of status epilepticus refractory to first-line agents
* Bronchodilation in severe asthma exacerbations (adjunctive therapy)
## Adult Dosing
* **Hypomagnesemia:**
* **Severe (serum Mg < 1.5 mEq/L):** 4-6 grams IV initially, followed by 2-4 grams IV every 4-12 hours, or by continuous infusion of 1-2 grams/hour.
* **Mild to Moderate (serum Mg 1.5-2.5 mEq/L):** 2-4 grams IV or IM.
* *Note:* Dosing can be adjusted based on serum magnesium levels and patient response.
* **Eclampsia/Pre-eclampsia:** 4-6 grams IV loading dose, followed by a maintenance infusion of 1-2 grams/hour. Alternatively, 5 grams IM in each buttock every 4 hours.
* **Torsades de Pointes:** 1-2 grams IV in 10 mL of D5W over 5-10 minutes. May repeat if necessary. Can also be given as a continuous infusion of 0.5-1 gram/hour.
* **Status Epilepticus (Refractory):** 1-2 grams IV over 5 minutes.
* **Asthma Exacerbation (Adjunctive):** 1-2 grams IV infusion over 15-30 minutes.
## Pediatric Dosing
* **Hypomagnesemia:** Dosing is highly variable and based on serum magnesium levels, weight, and clinical status. Common practice is 25-50 mg/kg IV, not to exceed 2 grams in 24 hours.
* **Eclampsia (Adjunctive to obstetric management):** Typically follows adult protocols, but specific dosing should be guided by pediatric critical care or toxicology consultation.
* **Status Epilepticus (Refractory):** 25-50 mg/kg IV, maximum dose 2 grams.
* **Asthma Exacerbation (Adjunctive):** 25-50 mg/kg IV, maximum dose 2 grams, infused over 15-30 minutes.
*Note: Pediatric dosing for hypomagnesemia and other indications can vary significantly and should be guided by expert consultation or specific institutional protocols.*
## Dose Adjustments
* **Renal Impairment:** Magnesium is renally excreted. Reduce dose and monitor serum magnesium levels closely in patients with impaired renal function. Avoid in severe renal failure if possible.
## Contraindications
* Hypermagnesemia
* Heart block
* Myocardial infarction
* Persistent vomiting
* Intestinal obstruction
* Rectal perforation
* Hypotension (relative)
* Severe myocardial depression
## Adverse Effects
* **Common:** Flushing, sweating, hypotension, somnolence, nausea, vomiting, decreased deep tendon reflexes.
* **Serious:** Respiratory depression, cardiac arrest, hypermagnesemia (especially with renal impairment), hyperthermia.
## Key Drug Interactions
* **Neuromuscular blocking agents:** May potentiate neuromuscular blockade.
* **Calcium channel blockers:** Increased risk of hypotension and cardiac depression.
* **Digoxin:** Risk of digoxin toxicity if magnesium levels are critically low.
* **Nifedipine:** Concomitant use in pre-term labor is generally discouraged due to risk of hypotension and impaired uterine contractility.
## Monitoring
* **Serum magnesium levels:** Essential for guiding dose adjustments, especially in patients with renal impairment and during prolonged infusions.
* **Renal function:** Monitor BUN and creatinine.
* **Vital signs:** Blood pressure, heart rate, respiratory rate.
* **Neurological status:** Deep tendon reflexes, mental status, seizure activity.
* **Urine output:** Adequate urine output is crucial for magnesium excretion.
* **ECG:** In cases of torsades de pointes or suspected cardiac effects.
## Clinical Pearls
* Magnesium sulfate is a central nervous system depressant.
* When treating hypomagnesemia, aim for a serum magnesium level of 2-3 mEq/L.
* Excessive doses can lead to magnesium toxicity. Signs include loss of deep tendon reflexes, altered mental status, and respiratory depression.
* Administer IV magnesium slowly to avoid hypotension and flushing.
* Magnesium sulfate is incompatible with many IV solutions and medications; administer in a separate IV line.
* Always check the concentration of magnesium sulfate (e.g., 50% solution = 4 mmol/mL or 4.9 g/10 mL) before preparation.
***
**Disclaimer:** This information is intended for healthcare professionals and is not a substitute for professional medical advice. Always consult the most current prescribing information, product literature, and institutional protocols for definitive guidance. Dosing and management decisions should be individualized based on patient-specific factors.
